Memo To File: How US FDA Decided Which Janssen Vaccine Drug Substance Batches Were OK To Use

 
• By Bowman Cox
  
Janssen COVID vaccine
fda bares thinking on vaccine drug substance cross-contamination issue

More from Manufacturing

More from Compliance